Which medication is useful for treating both pain and symptoms of depression in clients diagnosed with somatoform disorder?

Amitriptyline is recognized as an effective treatment option for both pain management and the symptoms of depression, particularly in patients diagnosed with somatoform disorder. This medication is a tricyclic antidepressant that works by influencing neurotransmitters in the brain, particularly serotonin and norepinephrine, which play a crucial role in mood regulation and pain perception.

In cases of somatoform disorder, where patients often present with physical symptoms that cannot be fully explained by medical conditions, addressing both pain and mood can be essential for treatment. Amitriptyline has been shown to help alleviate chronic pain conditions, which often accompany depressive symptoms, thus providing a dual benefit in the management of somatoform disorder.

While other options like Fluoxetine, Phenelzine, and Sertraline are also used for treating depression, they may not offer the same level of efficacy in pain management as Amitriptyline does. Fluoxetine and Sertraline are selective serotonin reuptake inhibitors (SSRIs), which are primarily focused on treating depression and may not directly address pain symptoms. Phenelzine is a monoamine oxidase inhibitor (MAOI) that can help with depression but is not typically recognized for managing pain. Therefore, Amitriptyline